PrEP Trials
Antiretroviral resistance is not an important risk of the oral tenofovir prophylaxis trial in Botswana: a simple mathematical modeling approach. Dawn K. Smith, Poloko Kebaabetswe, Kisanga Disasi, Douglas Fleming, Lynn Paxton, and Margarett Davis. PrEP Trials.
312 views • 22 slides